Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 51Recruiting 5Terminated 2Active not recruiting 2Withdrawn 1Unknown 1Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 8Sarcoma 1Gastrointestinal 1

Conditions

Sarcoma 46Osteosarcoma 15Dendritic Cell Sarcoma, Interdigitating 12Bone Neoplasms 11Rhabdomyosarcoma 9Gastrointestinal Stromal Tumors 8Sarcoma, Ewing 5Melanoma 5Sarcoma, Kaposi 4Recurrence 4Neurofibrosarcoma 4Neoplasms 4Liposarcoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Sarcoma, Alveolar Soft Part 3Ovarian Neoplasms 3Thyroid Neoplasms 2Sarcoma, Synovial 2Pancreatic Neoplasms 2Neurofibromatosis 1 2Neuroblastoma 2Medulloblastoma 2Lung Neoplasms 2Leiomyosarcoma 2Leiomyoma 2Hodgkin Disease 2Histiocytoma, Malignant Fibrous 2Head and Neck Neoplasms 2

Interventions

liposomal doxorubicin 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Acquired Immunodeficiency Syndrome × Sarcoma × Clear all
NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 3 Not yet recruiting
130 enrolled
Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡